Le Lézard
Classified in: Business
Subject: ATY

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Innodata Inc. - INOD


NEW YORK, April 12, 2024 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Innodata Inc. ("Innodata" or the "Company") (NASDAQ: INOD).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

The class action concerns whether Innodata and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

You have until April 22, 2024, to ask the Court to appoint you as Lead Plaintiff for the class if you are a shareholder who purchased or otherwise acquired Innodata securities during the Class Period. A copy of the Complaint can be obtained at www.pomerantzlaw.com.

[Click here for information about joining the class action]

On February 15, 2024, Wolfpack Research published a report (the "Wolfpack Report") revealing that Innodata misrepresented the nature and extent of its business and operations.  The Wolfpack Report purported to show that Innodata's AI is really "smoke and mirrors" and compared the Company's marketing claims to "putting lipstick on a pig."  Although Innodata touted its ostensible status as an AI pioneer, the Wolfpack Report alleged that other companies were only hiring Innodata for cheap labor and that its operations were powered by thousands of low-wage offshore workers, not proprietary AI technology.  The Company also stopped disclosing its Research and Development (R&D) spend after the first quarter of 2021.  The Wolfpack Report highlighted that Innodata's total investment in R&D over the past five years was only $4.4 million, with even less allocated to R&D in 2023 than what the Company spent promoting its "AI" technology through press releases.  

On this news, Innodata's stock price fell $3.74 per share, or 30.5%, to close at $8.52 per share on February 15, 2024.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered billions of dollars in damages awards on behalf of class members. See www.pomlaw.com.   

Attorney advertising. Prior results do not guarantee similar outcomes.   

CONTACT:
Danielle Peyton
Pomerantz LLP
[email protected]
646-581-9980 ext. 7980

SOURCE Pomerantz LLP


These press releases may also interest you

at 17:55
Sinovac Biotech Ltd. ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, has filed its 2023 annual report on Form 20-F with the U.S. Securities and Exchange Commission for the year ended December 31, 2023. The...

at 17:45
The Law Offices of Frank R. Cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against bluebird bio, Inc. ("bluebird" or the "Company") ....

at 17:40
Nexus Industrial REIT ("Nexus" or the "REIT") announced today that it intends to release its financial results for the quarter ended March 31, 2024, before the opening of the TSX on Wednesday May 15, 2024. Management of the REIT will host a...

at 17:28
PenFed Credit Union, the nation's second-largest federal credit union, announced today it will continue its partnership with Goulian Aerosports as a primary partner for the 2024-2025 air show seasons. This announcement builds on PenFed's 2022-2023...

at 17:28
Pomerantz LLP announces that a class action lawsuit has been filed against Akero Therapeutics, Inc. ("Akero" or the "Company") . Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW),...

at 17:26
Amped Fitness® has recently unveiled their highly anticipated luxury fitness oasis in the heart of West Palm Beach, FL. With fitness centers already booming throughout the South Florida area, Amped Fitness® is thrilled to announce their first ever...



News published on and distributed by: